AGIO vs BIIB: Which Stock is Better?
Side-by-side comparison of Agios Pharmaceuticals Inc and Biogen Inc in 2026
AGIO
Agios Pharmaceuticals Inc
$35.14
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | AGIO | BIIB | Winner |
|---|---|---|---|
| Market Cap | $2.05B | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | 0.9% | -0.1% | AGIO |
| Gross Margin | -540.2% | 78.9% | BIIB |
Analyze AGIO
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AGIO or BIIB a better investment?
Comparing AGIO and BIIB: Agios Pharmaceuticals Inc has a market cap of $2.05B while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AGIO and BIIB?
AGIO (Agios Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AGIO or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AGIO or BIIB?
AGIO has higher revenue growth at 0.9% vs -0.1% for BIIB.
Which company is more profitable: AGIO or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -540.2% for AGIO.
Which is the larger company: AGIO or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $2.05B for AGIO.
Should I buy AGIO or BIIB in 2026?
Both AGIO and BIIB have investment merit. AGIO trades at $35.14 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AGIO and BIIB stock?
Key differences: Market Cap ($2.05B vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.9% vs -0.1%), Gross Margin (-540.2% vs 78.9%).